CBLL compared with SION: revenue, margins and what each company keeps, and the suppliers and customers both name

CBLLCeribell, Inc.

Mkt capRevenueRevenue

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CBLLCeribell, Inc.

SIONSionna Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

CBLLCeribell, Inc.

26.66▲+2.50%· post 26.64· delayed

Mkt cap$1.0BRevenue$29MQ3 FY26Revenue$89MFY25

SIONSionna Therapeutics, Inc.

3.27▼−0.38%· post 3.23· delayed

After hoursNov 6 '26delayed

Mkt cap$148.1MRevenue—Revenue—

Compare

After hoursNov 6 '26delayed

CBLLCeribell, Inc.

SIONSionna Therapeutics, Inc.

26.66▲+2.50%post 26.64delayed

Price

3.27▼−0.38%post 3.23delayed

$1.0B

Mkt cap

$148.1M

Q3 FY26$29M

Revenue

—

FY25$89M

Revenue

—

CBLL26.66▲+2.50%vsSION3.27▼−0.38%After hoursNov 6 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CBLL 0

None

Shared 0

No disclosed counterparties: CBLL.

Only SION 4

ABBVAbbVie Global Enterprises Ltd. ("AbbVie")supplier

SNYSanofi SA ("Sanofi")supplier

—Galapagosunlistedsupplier

—Cystic Fibrosis Foundation (CFF)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR